← FDA Drug Approvals (Drugs@FDA)
DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
NDA · New Drug Application · Sponsor: LAURUS LABS LTD · Approved 2019-02-01
Drug application
- FDA Application #
NDA210787- Application type
- New Drug Application
- Brand name
- DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
- Generic name
- Dolutegravir
- Active ingredients
- DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- LAURUS LABS LTD
- First approval
- 2019-02-01
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown